Verrica Pharmaceuticals Inc. Common Stock (NASDAQ: VRCA) last traded at $4.82, down 0.82% on the session. The quote above updates while this page is open; the figures below are drawn from Verrica Pharmaceuticals Inc. Common Stock’s own filings and are restated only when a new one is published.
Verrica Pharmaceuticals Inc. Common Stock trades on NASDAQ under the ticker VRCA. Its market capitalisation is $82.80 million.
Valuation measures for Verrica Pharmaceuticals Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $82.80M |
|---|---|
| Enterprise value | $103.31M |
| Price / sales | 2.73 |
| Price / book | 19.22 |
| Beta | 2.04 |
Trailing-twelve-month figures tagged in Verrica Pharmaceuticals Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $30.32M |
|---|---|
| Net income (TTM) | -$31.18M |
| EPS (TTM) | -$1.74 |
| Operating margin | -93.59% |
| Return on equity | -724.01% |
| Cash | $11.20M |
Range and volume for VRCA over the past 52 weeks.
| 52-week high | $9.82 |
|---|---|
| 52-week low | $3.28 |
| Volume | 78.8K |
| Average volume | 46.7K |
| Previous close | $4.86 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.